214 related articles for article (PubMed ID: 32548365)
1. Current
Hamilton KA; Santhakumar V
Curr Opin Biomed Eng; 2020 Jun; 14():18-24. PubMed ID: 32548365
[TBL] [Abstract][Full Text] [Related]
2. Investigations on alterations of hippocampal circuit function following mild traumatic brain injury.
Smith CJ; Johnson BN; Elkind JA; See JM; Xiong G; Cohen AS
J Vis Exp; 2012 Nov; (69):e4411. PubMed ID: 23183856
[TBL] [Abstract][Full Text] [Related]
3. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels.
Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE
J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683
[TBL] [Abstract][Full Text] [Related]
4. Modeling of the brain-lung axis using organoids in traumatic brain injury: an updated review.
Kim JT; Song K; Han SW; Youn DH; Jung H; Kim KS; Lee HJ; Hong JY; Cho YJ; Kang SM; Jeon JP
Cell Biosci; 2024 Jun; 14(1):83. PubMed ID: 38909262
[TBL] [Abstract][Full Text] [Related]
5. Modeling traumatic brain injury with human brain organoids.
Jgamadze D; Johnson VE; Wolf JA; Cullen DK; Song H; Ming GL; Smith DH; Chen HI
Curr Opin Biomed Eng; 2020 Jun; 14():52-58. PubMed ID: 35434439
[TBL] [Abstract][Full Text] [Related]
6. An in vitro model of traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice cultures.
Morrison B; Cater HL; Benham CD; Sundstrom LE
J Neurosci Methods; 2006 Jan; 150(2):192-201. PubMed ID: 16098599
[TBL] [Abstract][Full Text] [Related]
7. Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities.
Golub VM; Reddy DS
Exp Neurol; 2022 Feb; 348():113946. PubMed ID: 34896334
[TBL] [Abstract][Full Text] [Related]
8. The Emergence of Model Systems to Investigate the Link Between Traumatic Brain Injury and Alzheimer's Disease.
Srinivasan G; Brafman DA
Front Aging Neurosci; 2021; 13():813544. PubMed ID: 35211003
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological Analysis of Brain Organoids: Current Approaches and Advancements.
Passaro AP; Stice SL
Front Neurosci; 2020; 14():622137. PubMed ID: 33510616
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Organoids as an Experimental Platform for Human Neurogenomics.
Nowakowski TJ; Salama SR
Cells; 2022 Sep; 11(18):. PubMed ID: 36139380
[TBL] [Abstract][Full Text] [Related]
12. Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury.
Lacalle-Aurioles M; Cassel de Camps C; Zorca CE; Beitel LK; Durcan TM
Front Cell Neurosci; 2020; 14():594304. PubMed ID: 33281561
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from bone marrow mesenchymal stem cells attenuate neurological damage in traumatic brain injury by alleviating glutamate-mediated excitotoxicity.
Zhuang Z; Liu M; Luo J; Zhang X; Dai Z; Zhang B; Chen H; Xue J; He M; Xu H; Liu A
Exp Neurol; 2022 Nov; 357():114182. PubMed ID: 35901975
[TBL] [Abstract][Full Text] [Related]
14. Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells.
Bose R; Banerjee S; Dunbar GL
Front Cell Dev Biol; 2021; 9():640212. PubMed ID: 34041235
[TBL] [Abstract][Full Text] [Related]
15. Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors.
Avaliani N; Sørensen AT; Ledri M; Bengzon J; Koch P; Brüstle O; Deisseroth K; Andersson M; Kokaia M
Stem Cells; 2014 Dec; 32(12):3088-98. PubMed ID: 25183299
[TBL] [Abstract][Full Text] [Related]
16. Organoids: the third dimension of human brain development and disease.
Kouroupi G; Prodromidou K; Papastefanaki F; Taoufik E; Matsas R
Int J Dev Biol; 2022; 66(1-2-3):23-33. PubMed ID: 34881786
[TBL] [Abstract][Full Text] [Related]
17. Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.
Kumar A; Stoica BA; Loane DJ; Yang M; Abulwerdi G; Khan N; Kumar A; Thom SR; Faden AI
J Neuroinflammation; 2017 Mar; 14(1):47. PubMed ID: 28292310
[TBL] [Abstract][Full Text] [Related]
18. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
